High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer (Q27851983)
Jump to navigation
Jump to search
scientific article
- High Expression of Class III β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer
Language | Label | Description | Also known as |
---|---|---|---|
English | High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer |
scientific article |
|
Statements
April 2013
0 references
13
0 references
2
0 references
103-8
0 references
1 reference